# Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

> **NCT00783081** · PHASE2 · COMPLETED · sponsor: **Kowa Research Institute, Inc.** · enrollment: 387 (actual)

## Conditions studied

- Intermittent Claudication

## Interventions

- **DRUG:** K-134
- **DRUG:** Cilostazol 100 mg BID
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00783081
- **Lead sponsor:** Kowa Research Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 387 (ACTUAL)
- **Last updated:** 2012-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00783081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00783081, "Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00783081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*